- Home
- AQMS vs CODX Comparison
AQMS vs CODX Comparison
Compare AQMS & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQMS
- CODX
- Stock Information
- Founded
- AQMS 2014
- CODX 2013
- Country
- AQMS United States
- CODX United States
- Employees
- AQMS N/A
- CODX N/A
- Industry
- AQMS Metal Fabrications
- CODX Medical/Dental Instruments
- Sector
- AQMS Industrials
- CODX Health Care
- Exchange
- AQMS Nasdaq
- CODX Nasdaq
- Market Cap
- AQMS 11.1M
- CODX 11.9M
- IPO Year
- AQMS 2015
- CODX 2017
- Fundamental
- Price
- AQMS $0.76
- CODX $0.30
- Analyst Decision
- AQMS Strong Buy
- CODX Buy
- Analyst Count
- AQMS 3
- CODX 2
- Target Price
- AQMS $21.00
- CODX $5.50
- AVG Volume (30 Days)
- AQMS 197.1K
- CODX 719.9K
- Earning Date
- AQMS 08-04-2025
- CODX 05-08-2025
- Dividend Yield
- AQMS N/A
- CODX N/A
- EPS Growth
- AQMS N/A
- CODX N/A
- EPS
- AQMS N/A
- CODX N/A
- Revenue
- AQMS N/A
- CODX $3,497,583.00
- Revenue This Year
- AQMS N/A
- CODX N/A
- Revenue Next Year
- AQMS $550.00
- CODX $42.11
- P/E Ratio
- AQMS N/A
- CODX N/A
- Revenue Growth
- AQMS N/A
- CODX N/A
- 52 Week Low
- AQMS $0.73
- CODX $0.23
- 52 Week High
- AQMS $8.20
- CODX $2.23
- Technical
- Relative Strength Index (RSI)
- AQMS 28.96
- CODX 48.86
- Support Level
- AQMS $0.73
- CODX $0.23
- Resistance Level
- AQMS $0.95
- CODX $0.32
- Average True Range (ATR)
- AQMS 0.07
- CODX 0.04
- MACD
- AQMS 0.01
- CODX 0.01
- Stochastic Oscillator
- AQMS 8.61
- CODX 67.38
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.